Renaissance Technologies LLC purchased a new position in Aeterna Zentaris Inc. (NASDAQ:AEZS) (TSE:AEZ) in the 2nd quarter, according to the company in its most recent Form 13F...
Aeterna Zentaris (AEZS): Q3 Net Finance Income of $0.1MRevenue of $0.6M (+500.0% Y/Y) in-line.Press Release
Investors in Aeterna Zentaris Inc. (TSX:AEZS) need to pay close attention to the stock based on moves in the options market lately. That is because the Aug 16, 2019 $7.50 Call...
Aeterna Zentaris Inc. (TO:AEZS) is likely to report its fourth-quarter 2018 earnings soon.Aeterna’s earnings performance has been encouraging, with the company beating...
Aeterna Zentaris Inc., a specialty biopharmaceutical company, engages in developing and commercializing therapeutics and diagnostic tests. Its lead product is macimorelin, a peptidomimetic ghrelin receptor (GHSR-1a) agonist that stimulates the secretion of growth hormone by binding to the GHSR-1a for the diagnosis of adult growth hormone deficiency and childhood-onset growth hormone deficiency, as well as oncology indications. The company markets macimorelin under the Macrilen name. Aeterna Zentaris Inc. has a license agreement with Julius-Maximilians-University Wuerzburg for the development of an oral prophylactic bacterial vaccine against COVID-19 disease; development, manufacture, and commercialization of targeted immunosuppressive therapeutic proteins for the treatment of neuromyelitis optica spectrum disorder. It also has a license agreement with Consilient Health Ltd. and Novo Nordisk Biopharm Limited for the development and commercialization of macimorelin in the United States and Canada, as well as The University of Sheffield, United Kingdom for the research, development, manufacture, and commercialization of parathyroid hormone fusion polypeptides for the treatment of primary hypoparathyroidism. Aeterna Zentaris Inc. was incorporated in 1990 and is headquartered in Summerville, South Carolina.
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Strong Sell | Strong Sell | Strong Sell | Strong Sell | Strong Sell |
| Technical Indicators | Strong Sell | Strong Sell | Strong Sell | Strong Sell | Strong Sell |
| Summary | Strong Sell | Strong Sell | Strong Sell | Strong Sell | Strong Sell |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 161.84 | 164.96 | 159.72 | -1.92 | -1.17% | 117.63M | NASDAQ | |||
| 2,840.00 | 2,888.00 | 2,806.00 | -19.3 | -0.67% | 1.96M | NASDAQ | |||
| 306.84 | 313.75 | 299.50 | -3.55 | -1.14% | 26.91M | NASDAQ | |||
| 56.23 | 56.82 | 55.67 | +0.08 | +0.14% | 26.15M | NASDAQ | |||
| 3,389.79 | 3,469.86 | 3,338.60 | -47.57 | -1.38% | 3.84M | NASDAQ | |||
| 223.92 | 229.04 | 221.72 | -4.60 | -2.01% | 1.31M | NASDAQ | |||
| 4.25 | 4.30 | 4.22 | -0.020 | -0.47% | 977.68K | NYSE | |||
| 54.27 | 54.41 | 53.10 | +1.23 | +2.32% | 37.06M | NYSE | |||
| 35.85 | 37.84 | 35.26 | -2.27 | -5.95% | 47.28M | NYSE | |||
| 349.08 | 353.39 | 346.01 | -1.99 | -0.57% | 331.65K | NASDAQ | |||
| 3.76 | 3.77 | 3.75 | +0.010 | +0.27% | 626.72K | NYSE | |||
| 86.62 | 88.27 | 86.04 | +0.57 | +0.66% | 1.48M | NYSE | |||
| 53.54 | 53.61 | 52.98 | +0.47 | +0.89% | 21.05M | NYSE | |||
| 172.59 | 172.91 | 169.18 | +2.33 | +1.37% | 3.02M | NYSE | |||
| 73.34 | 74.25 | 72.66 | -0.55 | -0.74% | 13.71M | NYSE |